InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA Clue Score53
United States Fiscal year ends December CIK 0001652130
$13.07 +3.73% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $13.07 −89.62% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue16.5Operating income−32.2Net income−31.6Fiscal year 2017Revenue26.1 +58.5%Operating income−69.6Net income−67.5Fiscal year 2018Revenue30.4 +16.5%Operating income−90.9Net income−85.3Fiscal year 2019Revenue43.1 +41.6%Operating income−106.4Net income−474.2Fiscal year 2020Revenue58.0 +34.5%Operating income−136.6Net income−134.2EPS, diluted−2.40Fiscal year 2021Revenue33.1 −43.0%Operating income−267.9Net income−267.9EPS, diluted−3.78Fiscal year 2022Revenue52.1 +57.7%Operating income−458.2Net income−474.2EPS, diluted−6.16Fiscal year 2023Revenue36.3 −30.4%Operating income−515.3Net income−481.2EPS, diluted−5.42Fiscal year 2024Revenue57.9 +59.6%Operating income−534.3Net income−519.0EPS, diluted−5.25Fiscal year 2025Revenue67.7 +16.9%Operating income−441.0Net income−412.7EPS, diluted−3.81
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 16.5 26.1 30.4 43.1 58.0 33.1 52.1 36.3 57.9 67.7
Growth +58.5% +16.5% +41.6% +34.5% −43.0% +57.7% −30.4% +59.6% +16.9%
Operating income −32.2 −69.6 −90.9 −106.4 −136.6 −267.9 −458.2 −515.3 −534.3 −441.0
Net income −31.6 −67.5 −85.3 −474.2 −134.2 −267.9 −474.2 −481.2 −519.0 −412.7
Growth
EPS, diluted n/a n/a n/a n/a −2.40 −3.78 −6.16 −5.42 −5.25 −3.81
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−195.2%Net margin−192.0%Free cash flow margin181.7%Fiscal year 2017Operating margin−266.3%Net margin−258.6%Free cash flow margin−288.6%Fiscal year 2018Operating margin−298.6%Net margin−280.4%Free cash flow margin−222.2%Fiscal year 2019Operating margin−246.8%Net margin−1,100.1%Free cash flow margin−255.3%Fiscal year 2020Operating margin−235.5%Net margin−231.5%Free cash flow margin−92.2%Fiscal year 2021Operating margin−810.4%Net margin−810.5%Free cash flow margin−719.4%Fiscal year 2022Operating margin−879.0%Net margin−909.8%Free cash flow margin−665.5%Fiscal year 2023Operating margin−1,420.5%Net margin−1,326.5%Free cash flow margin−1,124.9%Fiscal year 2024Operating margin−923.1%Net margin−896.8%Free cash flow margin−612.8%Fiscal year 2025Operating margin−651.7%Net margin−609.9%Free cash flow margin−585.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −195.2% −266.3% −298.6% −246.8% −235.5% −810.4% −879.0% −1,420.5% −923.1% −651.7%
Net margin −192.0% −258.6% −280.4% −1,100.1% −231.5% −810.5% −909.8% −1,326.5% −896.8% −609.9%
Free cash flow margin 181.7% −288.6% −222.2% −255.3% −92.2% −719.4% −665.5% −1,124.9% −612.8% −585.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow36.1Capital expenditure−6.2Free cash flow29.9Fiscal year 2017Operating cash flow−65.3Capital expenditure−10.1Free cash flow−75.4 −351.7%Fiscal year 2018Operating cash flow−61.3Capital expenditure−6.4Free cash flow−67.6Fiscal year 2019Operating cash flow−103.2Capital expenditure−6.8Free cash flow−110.0Fiscal year 2020Operating cash flow−49.9Capital expenditure−3.6Free cash flow−53.5Fiscal year 2021Operating cash flow−225.0Capital expenditure−12.8Free cash flow−237.8Fiscal year 2022Operating cash flow−333.3Capital expenditure−13.6Free cash flow−346.8Fiscal year 2023Operating cash flow−394.1Capital expenditure−14.0Free cash flow−408.1Fiscal year 2024Operating cash flow−348.9Capital expenditure−5.8Free cash flow−354.7Fiscal year 2025Operating cash flow−394.7Capital expenditure−1.1Free cash flow−395.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 36.1 −65.3 −61.3 −103.2 −49.9 −225.0 −333.3 −394.1 −348.9 −394.7
Capital expenditure −6.2 −10.1 −6.4 −6.8 −3.6 −12.8 −13.6 −14.0 −5.8 −1.1
Free cash flow 29.9 −75.4 −67.6 −110.0 −53.5 −237.8 −346.8 −408.1 −354.7 −395.9
Growth −351.7%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash273.1Shareholders’ equity209.8Fiscal year 2017Cash340.7Shareholders’ equity300.6Fiscal year 2018Cash58.9Shareholders’ equity277.9Fiscal year 2019Cash57.2Shareholders’ equity269.9Fiscal year 2020Cash160.0Shareholders’ equity527.1Fiscal year 2021Cash123.4Shareholders’ equity1,040.2Fiscal year 2022Cash523.5Shareholders’ equity1,235.6Fiscal year 2023Cash226.7Shareholders’ equity1,050.2Fiscal year 2024Cash189.2Shareholders’ equity872.0Fiscal year 2025Cash155.5Shareholders’ equity671.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 273.1 340.7 58.9 57.2 160.0 123.4 523.5 226.7 189.2 155.5
Shareholders’ equity 209.8 300.6 277.9 269.9 527.1 1,040.2 1,235.6 1,050.2 872.0 671.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
16.5 26.1 30.4 43.1 58.0 33.1 52.1 36.3 57.9 67.7
Growth +58.5% +16.5% +41.6% +34.5% −43.0% +57.7% −30.4% +59.6% +16.9%
n/a n/a 0.0 0.0 0.0 0.0 n/a n/a n/a n/a
31.8 67.6 89.1 108.4 150.4 229.8 420.0 435.1 466.3 388.9
16.8 28.0 32.2 41.1 44.2 71.1 90.3 116.5 125.8 119.8
−32.2 −69.6 −90.9 −106.4 −136.6 −267.9 −458.2 −515.3 −534.3 −441.0
Growth
−31.6 −67.5 n/a n/a n/a n/a n/a n/a n/a n/a
0.0 n/a n/a n/a n/a n/a n/a n/a n/a 0.0
−31.6 −67.5 −85.3 −474.2 −134.2 −267.9 −474.2 −481.2 −519.0 −412.7
Growth
Per share
n/a n/a n/a n/a −2.40 −3.78 −6.16 −5.42 −5.25 −3.81
n/a n/a n/a n/a −2.40 −3.78 −6.16 −5.42 −5.25 −3.81
Growth
n/a n/a n/a n/a 56.0 70.9 77.0 88.8 98.8 108.4
n/a n/a n/a n/a 56.0 70.9 77.0 88.8 98.8 108.4
Growth +26.6% +8.6% +15.3% +11.4% +9.6%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 3.1% a year over five years.
  • The diluted share count rose 93.6% in five years, which is dilution.
  • Operating margin is down 416.2 points on five years ago, at -651.7%.
  • A net loss in 10 of 10 years on file.